May 15, 2021 Comments Off on New patent for Astrazeneca Ab drug BYDUREON PEN Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fir…
May 15, 2021 Comments Off on New patent for Astrazeneca Ab drug BYDUREON Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty-six patents…
The post New patent for Astrazeneca Ab drug BYDUREON appeared first …
